APO RESEARCH · REPORT
Cefprozil
Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic, and it is a second-generation cephalosporin type antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.
Product & engineering
Understand the product.
Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic, and it is a second-generation cephalosporin type antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.
Selected research
Market Structure
Global Cefprozil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic, and it is a second-generation cephalosporin type antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.
Global Cefprozil key players include Orchid, Taj Pharma, Dhanuka, Qilu Antibiotics, Dongying Pharma, etc. Global top five manufacturers hold a share over 45%.
India is the largest market, with a share about 50%, followed by China, and Europe, both have a share about 40 percent.
Read the full market overview
In terms of product, Anhydrous is the largest segment, with a share over 60%. And in terms of application, the largest application is Uncomplicated Skin, followed by Pharyngitis or tonsillitis, Secondary Bacterial Infection, Acute Sinusitis, etc.
This report provides an overview of the global Cefprozil market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cefprozil and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cefprozil sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cefprozil market size, projected growth trends, production technologies, key applications, and end-use industries.
Cefprozil Segment by Company
Orchid
Taj Pharma
Dhanuka
Lupin
Alkem
Corden Pharma
Aurobindo
Covalent
TEVA GROUP
Hetero Drugs
Qilu Antibiotics
Dongying Pharma
Union Chempharma
Huafangpharm
Topfond
Cefprozil Segment by Type
Anhydrous
Monohydrate
Cefprozil Segment by Application
Pharyngitis or tonsillitis
Otitis Media
Acute Sinusitis
Secondary Bacterial Infection
Uncomplicated Skin
Other
Cefprozil Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cefprozil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cefprozil and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cefprozil.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cefprozil market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cefprozil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cefprozil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cefprozil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Anhydrous
- Monohydrate
Applications
- Pharyngitis or tonsillitis
- Otitis Media
- Acute Sinusitis
- Secondary Bacterial Infection
- Uncomplicated Skin
- Other
Companies covered
- Orchid
- Taj Pharma
- Dhanuka
- Lupin
- Alkem
- Corden Pharma
- Aurobindo
- Covalent
- TEVA GROUP
- Hetero Drugs
- Qilu Antibiotics
- Dongying Pharma
- Union Chempharma
- Huafangpharm
- Topfond
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cefprozil Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cefprozil Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Cefprozil Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Cefprozil Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Cefprozil Market Dynamics
- 2.1 Cefprozil Industry Trends
- 2.2 Cefprozil Industry Drivers
- 2.3 Cefprozil Industry Opportunities and Challenges
- 2.4 Cefprozil Industry Restraints
3 Cefprozil Market by Manufacturers
- 3.1 Global Cefprozil Revenue by Manufacturers (2021-2026)
- 3.2 Global Cefprozil Sales by Manufacturers (2021-2026)
- 3.3 Global Cefprozil Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Cefprozil Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cefprozil Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cefprozil Manufacturers, Product Type & Application
- 3.7 Global Cefprozil Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cefprozil Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cefprozil Players Market Share by Revenue in 2025
- 3.8.3 2025 Cefprozil Tier 1, Tier 2, and Tier 3
4 Cefprozil Market by Type
- 4.1 Cefprozil Type Introduction
- 4.1.1 Anhydrous
- 4.1.2 Monohydrate
- 4.2 Global Cefprozil Sales by Type
- 4.2.1 Global Cefprozil Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cefprozil Sales by Type (2021-2032)
- 4.2.3 Global Cefprozil Sales Market Share by Type (2021-2032)
- 4.3 Global Cefprozil Revenue by Type
- 4.3.1 Global Cefprozil Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cefprozil Revenue by Type (2021-2032)
- 4.3.3 Global Cefprozil Revenue Market Share by Type (2021-2032)
5 Cefprozil Market by Application
- 5.1 Cefprozil Application Introduction
- 5.1.1 Pharyngitis or tonsillitis
- 5.1.2 Otitis Media
- 5.1.3 Acute Sinusitis
- 5.1.4 Secondary Bacterial Infection
- 5.1.5 Uncomplicated Skin
- 5.1.6 Other
- 5.2 Global Cefprozil Sales by Application
- 5.2.1 Global Cefprozil Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cefprozil Sales by Application (2021-2032)
- 5.2.3 Global Cefprozil Sales Market Share by Application (2021-2032)
- 5.3 Global Cefprozil Revenue by Application
- 5.3.1 Global Cefprozil Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cefprozil Revenue by Application (2021-2032)
- 5.3.3 Global Cefprozil Revenue Market Share by Application (2021-2032)
6 Global Cefprozil Sales by Region
- 6.1 Global Cefprozil Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cefprozil Sales by Region (2021-2032)
- 6.2.1 Global Cefprozil Sales by Region (2021-2026)
- 6.2.2 Global Cefprozil Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cefprozil Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cefprozil Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cefprozil Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cefprozil Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cefprozil Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cefprozil Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Cefprozil Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Cefprozil Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Cefprozil Revenue by Region
- 7.1 Global Cefprozil Revenue by Region
- 7.1.1 Global Cefprozil Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Cefprozil Revenue by Region (2021-2026)
- 7.1.3 Global Cefprozil Revenue by Region (2027-2032)
- 7.1.4 Global Cefprozil Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Cefprozil Revenue (2021-2032)
- 7.2.2 North America Cefprozil Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Cefprozil Revenue (2021-2032)
- 7.3.2 Europe Cefprozil Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Cefprozil Revenue (2021-2032)
- 7.4.2 Asia-Pacific Cefprozil Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Cefprozil Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Cefprozil Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Orchid
- 8.1.1 Orchid Company Information
- 8.1.2 Orchid Business Overview
- 8.1.3 Orchid Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Orchid Cefprozil Product Portfolio
- 8.1.5 Orchid Recent Developments
- 8.2 Taj Pharma
- 8.2.1 Taj Pharma Company Information
- 8.2.2 Taj Pharma Business Overview
- 8.2.3 Taj Pharma Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Taj Pharma Cefprozil Product Portfolio
- 8.2.5 Taj Pharma Recent Developments
- 8.3 Dhanuka
- 8.3.1 Dhanuka Company Information
- 8.3.2 Dhanuka Business Overview
- 8.3.3 Dhanuka Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Dhanuka Cefprozil Product Portfolio
- 8.3.5 Dhanuka Recent Developments
- 8.4 Lupin
- 8.4.1 Lupin Company Information
- 8.4.2 Lupin Business Overview
- 8.4.3 Lupin Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Lupin Cefprozil Product Portfolio
- 8.4.5 Lupin Recent Developments
- 8.5 Alkem
- 8.5.1 Alkem Company Information
- 8.5.2 Alkem Business Overview
- 8.5.3 Alkem Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Alkem Cefprozil Product Portfolio
- 8.5.5 Alkem Recent Developments
- 8.6 Corden Pharma
- 8.6.1 Corden Pharma Company Information
- 8.6.2 Corden Pharma Business Overview
- 8.6.3 Corden Pharma Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Corden Pharma Cefprozil Product Portfolio
- 8.6.5 Corden Pharma Recent Developments
- 8.7 Aurobindo
- 8.7.1 Aurobindo Company Information
- 8.7.2 Aurobindo Business Overview
- 8.7.3 Aurobindo Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Aurobindo Cefprozil Product Portfolio
- 8.7.5 Aurobindo Recent Developments
- 8.8 Covalent
- 8.8.1 Covalent Company Information
- 8.8.2 Covalent Business Overview
- 8.8.3 Covalent Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Covalent Cefprozil Product Portfolio
- 8.8.5 Covalent Recent Developments
- 8.9 TEVA GROUP
- 8.9.1 TEVA GROUP Company Information
- 8.9.2 TEVA GROUP Business Overview
- 8.9.3 TEVA GROUP Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 TEVA GROUP Cefprozil Product Portfolio
- 8.9.5 TEVA GROUP Recent Developments
- 8.10 Hetero Drugs
- 8.10.1 Hetero Drugs Company Information
- 8.10.2 Hetero Drugs Business Overview
- 8.10.3 Hetero Drugs Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Hetero Drugs Cefprozil Product Portfolio
- 8.10.5 Hetero Drugs Recent Developments
- 8.11 Qilu Antibiotics
- 8.11.1 Qilu Antibiotics Company Information
- 8.11.2 Qilu Antibiotics Business Overview
- 8.11.3 Qilu Antibiotics Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Qilu Antibiotics Cefprozil Product Portfolio
- 8.11.5 Qilu Antibiotics Recent Developments
- 8.12 Dongying Pharma
- 8.12.1 Dongying Pharma Company Information
- 8.12.2 Dongying Pharma Business Overview
- 8.12.3 Dongying Pharma Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Dongying Pharma Cefprozil Product Portfolio
- 8.12.5 Dongying Pharma Recent Developments
- 8.13 Union Chempharma
- 8.13.1 Union Chempharma Company Information
- 8.13.2 Union Chempharma Business Overview
- 8.13.3 Union Chempharma Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Union Chempharma Cefprozil Product Portfolio
- 8.13.5 Union Chempharma Recent Developments
- 8.14 Huafangpharm
- 8.14.1 Huafangpharm Company Information
- 8.14.2 Huafangpharm Business Overview
- 8.14.3 Huafangpharm Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Huafangpharm Cefprozil Product Portfolio
- 8.14.5 Huafangpharm Recent Developments
- 8.15 Topfond
- 8.15.1 Topfond Company Information
- 8.15.2 Topfond Business Overview
- 8.15.3 Topfond Cefprozil Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Topfond Cefprozil Product Portfolio
- 8.15.5 Topfond Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Cefprozil Value Chain Analysis
- 9.1.1 Cefprozil Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cefprozil Production Mode & Process
- 9.2 Cefprozil Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cefprozil Distributors
- 9.2.3 Cefprozil Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst